Doctor profile · Federal record

Dr. Benito Marranzini, M.D.

Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · El Paso, TX

  • NPI 1083617328
  • Accepts Medicare
  • MIPS 75.0 / 100 · 2023
  • 34 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1516 Lomaland Dr.
El Paso, TX 79935
(915) 593-2600
fax (915) 593-2609

Credentials & registration

NPPES · NUCC
NPI registered
May 2005 — 21 yrs on file
Profile last updated
May 25, 2016
Year of graduation
1992 — 34 yrs since
Specialty taxonomy
207RE0101X — NUCC code
State license (1)
Texas #L9341

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1083617328. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
798
Distinct HCPCS
6
Medicare allowed
$101,135
HCPCS Description Services Patients Avg allowed
99214 Established patient office or other outpatient visit, 30-39 minutes 603 247 $122
99215 Established patient office or other outpatient visit, 40-54 minutes 116 93 $167
99205 New patient office or other outpatient visit, 60-74 minutes 29 29 $211
99213 Established patient office or other outpatient visit, 20-29 minutes 20 20 $83
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 17 13 $33
83036 Hemoglobin a1c level 13 11 $9

In context: peer comparison

Among 6 peers in this city , average services per provider: 116. This provider delivers 6.9× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$5,330
Transactions
235
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Dexcom, Inc. 22 $529.91
Lilly USA, LLC 30 $527.58
Novo Nordisk Inc 17 $423.95
Amgen Inc. 12 $389.72
Insulet Corporation 21 $330.73
Bayer Healthcare Pharmaceuticals Inc. 26 $323.11
Corcept Therapeutics 16 $314.26
ABBVIE INC. 18 $266.12
Boehringer Ingelheim Pharmaceuticals, Inc. 13 $208.37
Regeneron Healthcare Solutions, Inc. 9 $207.74
Novartis Pharmaceuticals Corporation 13 $188.90
Tandem Diabetes Care, Inc. 9 $179.62
RECORDATI_RARE_DISEASES_INC. 8 $174.08
Antares Pharma, Inc. 12 $155.20
Abbott Laboratories 9 $154.98

By nature of payment

Food and Beverage
$5,330

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
6,774
Patients
2,167
Total drug cost
$3,318,132
Drug Type Claims Patients Total cost
Levothyroxine Sodium Generic 1,855 521 $27,145
Ozempic (Semaglutide) Brand 858 206 $1,491,563
Metformin Hcl Generic 551 181 $5,558
Atorvastatin Calcium Generic 549 206 $7,186
Jardiance (Empagliflozin) Brand 465 133 $662,748
Rosuvastatin Calcium Generic 369 149 $6,506
Glipizide Generic 268 97 $3,278
Synthroid (Levothyroxine Sodium) Brand 267 68 $26,261
Ezetimibe Generic 256 88 $12,144
Alendronate Sodium Generic 255 95 $3,638

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Benito Marranzini's medical specialty?
Dr. Benito Marranzini practices Endocrinology, Diabetes & Metabolism Physician in El Paso, TX.
Where does Dr. Benito Marranzini practice?
Dr. Benito Marranzini practices at 1516 Lomaland Dr., El Paso, TX 79935. Office phone: 9155932600.
What is Dr. Benito Marranzini's NPI?
Dr. Benito Marranzini's National Provider Identifier (NPI) is 1083617328, issued by NPPES.
Does Dr. Benito Marranzini accept Medicare assignment?
Yes. Dr. Benito Marranzini accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Benito Marranzini commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99215); New patient office or other outpatient visit (HCPCS 99205). Source: CMS Medicare Physician & Other Practitioners file.